Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong
· Delayed Price · Currency is HKD 38.30
+0.42 (1.11%)
At close: Dec 5, 2025
Giant Biogene Holding Revenue
Giant Biogene Holding had revenue of 3.11B CNY in the half year ending June 30, 2025, with 93.85% growth. This brings the company's revenue in the last twelve months to 6.11B, up 37.05% year-over-year. In the year 2024, Giant Biogene Holding had annual revenue of 5.54B with 57.17% growth.
Revenue (ttm)
6.11B CNY
Revenue Growth
+37.05%
P/S Ratio
6.13
Revenue / Employee
3.48M CNY
Employees
1,758
Market Cap
41.02B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nongfu Spring | 50.78B |
| MIXUE Group | 31.81B |
| WH Group | 212.22B |
| Budweiser Brewing Company APAC | 45.38B |
| China Resources Beer (Holdings) Company | 42.55B |
| Smoore International Holdings | 14.89B |
| Tingyi (Cayman Islands) Holding | 87.16B |
| New Oriental Education & Technology Group | 38.88B |
Giant Biogene Holding News
- 6 months ago - Giant Biogene Bruised In A 'Battle Of The Skincare Belles' - Benzinga